Advertising Branding Event False Advertising 
43(B)log
APRIL 25, 2023
A jury found that defendant HBI engaged in unfair competition and violated the Illinois Uniform Deceptive Trade Practices Act (IUDTPA” in its packaging and promotional activities for its RAW Organic Hemp branded tobacco rolling paper products. The court granted an injunction focusing on the Alcoy claims, which were false.
43(B)log
NOVEMBER 28, 2022
2, 2022) Before the jury verdict in favor of Monster’s false advertising claim was this opinion resolving evidentiary issues. They weren’t directly asked about the phrase “Super Creatine,” whether participants had prior experiences with or opinions of Bang, or whether they had seen Vital’s advertising in the market.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Technology & Marketing Law Blog
JULY 25, 2021
Aliign “is an event, lifestyle, and apparel company” allegedly with a first trademark use in 2011. lululemon’s brand also displays prominently in its keyword ads. More Posts About Keyword Advertising. Ohio Bans Competitive Keyword Advertising by Lawyers. lululemon is the well-known yoga gear company.
The IPKat
JUNE 13, 2022
Despite the uncertainty around the long-term success of NFTs, we have certainly seen a “land grab” from brands filing trade marks, including ITV (for LOVE ISLAND), Heineken and even The Empire State Building [Katpost with details from Becky Knott here ].
43(B)log
AUGUST 17, 2021
Plaintiffs sued for false advertising and false endorsement under the Lanham Act, violation of their right to publicity, deceptive trade practices under New York GBL Section 349, and defamation. 2021), which considered all these claims except for false advertising. The court was guided by Electra v. 3d 233 (2d Cir.
43(B)log
OCTOBER 6, 2021
American Girl Brands, LLC, 2021 WL 510729, No. Walkowicz alleges that at least one American Girl employee or consultant attended multiple events at which they discussed their work. I will note here, as I often do, that in a false advertising case these allegations would likely be treated as conclusory at best.
43(B)log
MARCH 20, 2023
In 2010, the FDA decided to put information about diminished effectiveness for poor responders, associated with a particular genetic variant, in a black box warning, including language stating that poor metabolizers taking Plavix are more likely to have adverse cardiac events on the drug than non-poor responders.
Expert insights. Personalized for you.
57 
Let's personalize your content